Reliability and Validity of Modified Four Square Step Test

September 21, 2021 updated by: Emel Taşvuran Horata, Afyonkarahisar Health Sciences University

Evaluation of Test-retest Reliability, Concurrent Validity and Minimal Detectable Change of the Modified Four Square Step Test in Individuals With Primary Total Hip Arthroplasty.

Functional improvements are reached in patients with primary total hip arthroplasty compared to the pre-operative term however some problems as continued range of motion limitations, loss of joint proprioception sensation, and resulting balance and gait disorders may result in failure of the Four Square Step Test. Therefore, the need for the apply of the Modified Four Square Step Test in individuals with primary THA is necessary. The aim of this study is to evaluate the test-retest reliability, concurrent validity and minimal detectable change of the Modified Four Square Step Test in individuals with primary total hip arthroplasty.

Study Overview

Status

Recruiting

Detailed Description

Roos et al. improved the Modified Four-Square Step Test to complete the test by stroke patients and not to fall due to practices of the test while performing the test. The Modified Four Square Step Test variates from the The Four Square Step Test is that the person is not asked to look ahead during the test, and instead of using a cane, tapes are used to prevent people from losing their balance by tripping over the obstacle. Thus, although the height of the obstacle is reduced, the boundaries of the obstacle are preserved.

Functional improvements are reached in patients with primary total hip arthroplasty compared to the pre-operative term however some problems as continued range of motion limitations, loss of joint proprioception sensation, and resulting balance and gait disorders may result in failure of the Four Square Step Test. Therefore, the need for the apply of the Modified Four Square Step Test in individuals with primary THA is necessary. The aim of this study is to evaluate the test-retest reliability, concurrent validity and minimal detectable change of the Modified Four Square Step Test in individuals with primary total hip arthroplasty.

Study Type

Observational

Enrollment (Anticipated)

28

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Afyonkarahisar, Turkey, 03030
        • Recruiting
        • Afyonkarahisar Health Science University
        • Contact:
        • Principal Investigator:
          • EMEL TAŞVURAN HORATA, PhD
        • Sub-Investigator:
          • Fatma EKEN
        • Sub-Investigator:
          • MURAT YEŞİL, MD
        • Sub-Investigator:
          • ÖZAL ÖZCAN, Prof

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 83 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

In this study, the participants will consist of individuals who have previously undergone primary total hip arthroplasty in Afyonkarahisar Health Sciences University Health Practice and Research Center Orthopedics and Traumatology Polyclinic.

Description

Inclusion Criteria:

  • Being between the ages of 18-85.
  • Having undergone primary total hip arthroplasty at least ≥6 months ago.

Exclusion Criteria:

  • Having severe cardiovascular or lung disease
  • Having severe dementia or communication difficulties
  • Having a musculoskeletal or neurological problem that may affect participation in balance tests
  • Having an uncorrectable visual impairment
  • Having a body mass index of more than 40 kg/m2

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dynamic Balance
Time Frame: 6 minutes
Dynamic balance is the ability of an object to balance while in motion or switching between positions. Dynamic balance will be evaluated with the modified four square step test. The duration as second will be recorded.
6 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dynamic Balance
Time Frame: 4 minutes
Dynamic balance will be evaluated with the timed and go test and the test completion time will be recorded in seconds.
4 minutes
Dynamic Balance
Time Frame: 25 minutes
Dynamic balance will be evaluated with the Berg Balance Test. The scores from the test will be recorded.
25 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Emel TAŞVURAN HORATA, PhD, Afyonkarahisar Health Science University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2021

Primary Completion (Anticipated)

September 1, 2022

Study Completion (Anticipated)

September 1, 2023

Study Registration Dates

First Submitted

September 10, 2021

First Submitted That Met QC Criteria

September 21, 2021

First Posted (Actual)

September 23, 2021

Study Record Updates

Last Update Posted (Actual)

September 23, 2021

Last Update Submitted That Met QC Criteria

September 21, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 2021/414

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Total Hip Arthroplasty

3
Subscribe